← All trials
NCT02008877
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2013
- Primary completion
- Jun 1, 2017
- Completion date
- Dec 1, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 38
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Sarcoma Alliance for Research through CollaborationLead sponsor
- National Cancer Institute (NCI)Overall official - principal investigator
- Children's National Medical CenterOverall official - principal investigator
- Synta Pharmaceuticals Corp.Collaborator
- Department of DefenseCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.